On the contrary, tumor-infiltrating Vδ1 T cells promoted tumor development by secreting IL-17 and inhibiting the maturation of CD4/CD8 T cells and DC (44). γδ T cells have been used in clinical anti-tumor therapy and have achieved good results. The gene discussed is IL17A; the disease is neoplasm.